nodes	percent_of_prediction	percent_of_DWPC	metapath
Atenolol—ABCB1—Methylprednisolone—multiple sclerosis	0.144	0.232	CbGbCtD
Atenolol—ABCB1—Mitoxantrone—multiple sclerosis	0.105	0.169	CbGbCtD
Atenolol—ABCB1—Betamethasone—multiple sclerosis	0.0936	0.151	CbGbCtD
Atenolol—ABCB1—Prednisolone—multiple sclerosis	0.0923	0.149	CbGbCtD
Atenolol—ABCB1—Prednisone—multiple sclerosis	0.0872	0.141	CbGbCtD
Atenolol—ABCB1—Dexamethasone—multiple sclerosis	0.0544	0.0878	CbGbCtD
Atenolol—ABCB1—Methotrexate—multiple sclerosis	0.0437	0.0705	CbGbCtD
Atenolol—Chlorphenesin—BCHE—multiple sclerosis	0.00122	0.845	CrCbGaD
Atenolol—Hallucination—Dexamethasone—multiple sclerosis	0.000648	0.00172	CcSEcCtD
Atenolol—Hallucination—Betamethasone—multiple sclerosis	0.000648	0.00172	CcSEcCtD
Atenolol—Dermatitis—Cladribine—multiple sclerosis	0.000648	0.00171	CcSEcCtD
Atenolol—Anorexia—Mitoxantrone—multiple sclerosis	0.000645	0.00171	CcSEcCtD
Atenolol—Ataxia—Methotrexate—multiple sclerosis	0.000645	0.00171	CcSEcCtD
Atenolol—Headache—Cladribine—multiple sclerosis	0.000645	0.00171	CcSEcCtD
Atenolol—Arrhythmia—Triamcinolone—multiple sclerosis	0.000642	0.0017	CcSEcCtD
Atenolol—Vision blurred—Prednisolone—multiple sclerosis	0.000641	0.00169	CcSEcCtD
Atenolol—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00064	0.00169	CcSEcCtD
Atenolol—Hypotension—Mitoxantrone—multiple sclerosis	0.000632	0.00167	CcSEcCtD
Atenolol—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000631	0.00167	CcSEcCtD
Atenolol—Depression—Prednisone—multiple sclerosis	0.00063	0.00167	CcSEcCtD
Atenolol—Visual impairment—Betamethasone—multiple sclerosis	0.000628	0.00166	CcSEcCtD
Atenolol—Visual impairment—Dexamethasone—multiple sclerosis	0.000628	0.00166	CcSEcCtD
Atenolol—Myocardial infarction—Prednisone—multiple sclerosis	0.00062	0.00164	CcSEcCtD
Atenolol—Malaise—Prednisolone—multiple sclerosis	0.000613	0.00162	CcSEcCtD
Atenolol—Nausea—Cladribine—multiple sclerosis	0.000611	0.00162	CcSEcCtD
Atenolol—Vertigo—Prednisolone—multiple sclerosis	0.000611	0.00162	CcSEcCtD
Atenolol—Syncope—Prednisolone—multiple sclerosis	0.00061	0.00161	CcSEcCtD
Atenolol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000607	0.00161	CcSEcCtD
Atenolol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000603	0.0016	CcSEcCtD
Atenolol—Somnolence—Mitoxantrone—multiple sclerosis	0.000601	0.00159	CcSEcCtD
Atenolol—Loss of consciousness—Prednisolone—multiple sclerosis	0.000598	0.00158	CcSEcCtD
Atenolol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000595	0.00157	CcSEcCtD
Atenolol—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000588	0.00156	CcSEcCtD
Atenolol—Fatigue—Mitoxantrone—multiple sclerosis	0.000583	0.00154	CcSEcCtD
Atenolol—Arrhythmia—Betamethasone—multiple sclerosis	0.000582	0.00154	CcSEcCtD
Atenolol—Arrhythmia—Dexamethasone—multiple sclerosis	0.000582	0.00154	CcSEcCtD
Atenolol—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.00058	0.00153	CcSEcCtD
Atenolol—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000579	0.00153	CcSEcCtD
Atenolol—Pain—Mitoxantrone—multiple sclerosis	0.000578	0.00153	CcSEcCtD
Atenolol—Constipation—Mitoxantrone—multiple sclerosis	0.000578	0.00153	CcSEcCtD
Atenolol—Bradycardia—Prednisone—multiple sclerosis	0.000578	0.00153	CcSEcCtD
Atenolol—Alopecia—Betamethasone—multiple sclerosis	0.000576	0.00152	CcSEcCtD
Atenolol—Alopecia—Dexamethasone—multiple sclerosis	0.000576	0.00152	CcSEcCtD
Atenolol—Diarrhoea—Azathioprine—multiple sclerosis	0.000572	0.00151	CcSEcCtD
Atenolol—Discomfort—Prednisolone—multiple sclerosis	0.000572	0.00151	CcSEcCtD
Atenolol—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000568	0.0015	CcSEcCtD
Atenolol—Hallucination—Prednisone—multiple sclerosis	0.000565	0.00149	CcSEcCtD
Atenolol—Malaise—Triamcinolone—multiple sclerosis	0.000564	0.00149	CcSEcCtD
Atenolol—Malaise—Methylprednisolone—multiple sclerosis	0.000563	0.00149	CcSEcCtD
Atenolol—Vertigo—Triamcinolone—multiple sclerosis	0.000562	0.00149	CcSEcCtD
Atenolol—Syncope—Triamcinolone—multiple sclerosis	0.000561	0.00148	CcSEcCtD
Atenolol—Vertigo—Methylprednisolone—multiple sclerosis	0.00056	0.00148	CcSEcCtD
Atenolol—Syncope—Methylprednisolone—multiple sclerosis	0.000559	0.00148	CcSEcCtD
Atenolol—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000557	0.00147	CcSEcCtD
Atenolol—Oedema—Prednisolone—multiple sclerosis	0.000555	0.00147	CcSEcCtD
Atenolol—Dizziness—Azathioprine—multiple sclerosis	0.000553	0.00146	CcSEcCtD
Atenolol—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00055	0.00145	CcSEcCtD
Atenolol—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000548	0.00145	CcSEcCtD
Atenolol—Shock—Prednisolone—multiple sclerosis	0.000546	0.00144	CcSEcCtD
Atenolol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000546	0.00144	CcSEcCtD
Atenolol—Cough—Triamcinolone—multiple sclerosis	0.000546	0.00144	CcSEcCtD
Atenolol—Tachycardia—Prednisolone—multiple sclerosis	0.000542	0.00143	CcSEcCtD
Atenolol—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000536	0.00142	CcSEcCtD
Atenolol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000535	0.00141	CcSEcCtD
Atenolol—Anxiety—Methylprednisolone—multiple sclerosis	0.000529	0.0014	CcSEcCtD
Atenolol—Drowsiness—Methotrexate—multiple sclerosis	0.000528	0.0014	CcSEcCtD
Atenolol—Rash—Azathioprine—multiple sclerosis	0.000528	0.0014	CcSEcCtD
Atenolol—Dermatitis—Azathioprine—multiple sclerosis	0.000527	0.00139	CcSEcCtD
Atenolol—Depression—Methotrexate—multiple sclerosis	0.000527	0.00139	CcSEcCtD
Atenolol—Flushing—Prednisone—multiple sclerosis	0.000527	0.00139	CcSEcCtD
Atenolol—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000526	0.00139	CcSEcCtD
Atenolol—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000526	0.00139	CcSEcCtD
Atenolol—Discomfort—Triamcinolone—multiple sclerosis	0.000526	0.00139	CcSEcCtD
Atenolol—Discomfort—Methylprednisolone—multiple sclerosis	0.000525	0.00139	CcSEcCtD
Atenolol—Headache—Azathioprine—multiple sclerosis	0.000524	0.00139	CcSEcCtD
Atenolol—Dry mouth—Triamcinolone—multiple sclerosis	0.000521	0.00138	CcSEcCtD
Atenolol—Renal failure—Methotrexate—multiple sclerosis	0.000519	0.00137	CcSEcCtD
Atenolol—Confusional state—Methylprednisolone—multiple sclerosis	0.000513	0.00136	CcSEcCtD
Atenolol—Malaise—Betamethasone—multiple sclerosis	0.000512	0.00135	CcSEcCtD
Atenolol—Malaise—Dexamethasone—multiple sclerosis	0.000512	0.00135	CcSEcCtD
Atenolol—Oedema—Triamcinolone—multiple sclerosis	0.00051	0.00135	CcSEcCtD
Atenolol—Vertigo—Dexamethasone—multiple sclerosis	0.00051	0.00135	CcSEcCtD
Atenolol—Vertigo—Betamethasone—multiple sclerosis	0.00051	0.00135	CcSEcCtD
Atenolol—Syncope—Betamethasone—multiple sclerosis	0.000509	0.00135	CcSEcCtD
Atenolol—Syncope—Dexamethasone—multiple sclerosis	0.000509	0.00135	CcSEcCtD
Atenolol—Arrhythmia—Prednisone—multiple sclerosis	0.000507	0.00134	CcSEcCtD
Atenolol—Sweating—Methotrexate—multiple sclerosis	0.000507	0.00134	CcSEcCtD
Atenolol—Shock—Triamcinolone—multiple sclerosis	0.000502	0.00133	CcSEcCtD
Atenolol—Insomnia—Prednisolone—multiple sclerosis	0.000502	0.00133	CcSEcCtD
Atenolol—Alopecia—Prednisone—multiple sclerosis	0.000502	0.00133	CcSEcCtD
Atenolol—Shock—Methylprednisolone—multiple sclerosis	0.000501	0.00133	CcSEcCtD
Atenolol—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000499	0.00132	CcSEcCtD
Atenolol—Loss of consciousness—Betamethasone—multiple sclerosis	0.000499	0.00132	CcSEcCtD
Atenolol—Epistaxis—Methotrexate—multiple sclerosis	0.000498	0.00132	CcSEcCtD
Atenolol—Paraesthesia—Prednisolone—multiple sclerosis	0.000498	0.00132	CcSEcCtD
Atenolol—Tachycardia—Triamcinolone—multiple sclerosis	0.000498	0.00132	CcSEcCtD
Atenolol—Nausea—Azathioprine—multiple sclerosis	0.000497	0.00131	CcSEcCtD
Atenolol—Tachycardia—Methylprednisolone—multiple sclerosis	0.000497	0.00131	CcSEcCtD
Atenolol—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000493	0.0013	CcSEcCtD
Atenolol—Agranulocytosis—Methotrexate—multiple sclerosis	0.000493	0.0013	CcSEcCtD
Atenolol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000492	0.0013	CcSEcCtD
Atenolol—Asthenia—Mitoxantrone—multiple sclerosis	0.000485	0.00128	CcSEcCtD
Atenolol—Anxiety—Dexamethasone—multiple sclerosis	0.000481	0.00127	CcSEcCtD
Atenolol—Anxiety—Betamethasone—multiple sclerosis	0.000481	0.00127	CcSEcCtD
Atenolol—Discomfort—Betamethasone—multiple sclerosis	0.000477	0.00126	CcSEcCtD
Atenolol—Discomfort—Dexamethasone—multiple sclerosis	0.000477	0.00126	CcSEcCtD
Atenolol—Hypotension—Methylprednisolone—multiple sclerosis	0.000476	0.00126	CcSEcCtD
Atenolol—Pain—Prednisolone—multiple sclerosis	0.000474	0.00126	CcSEcCtD
Atenolol—Vision blurred—Prednisone—multiple sclerosis	0.000466	0.00123	CcSEcCtD
Atenolol—Oedema—Dexamethasone—multiple sclerosis	0.000463	0.00122	CcSEcCtD
Atenolol—Oedema—Betamethasone—multiple sclerosis	0.000463	0.00122	CcSEcCtD
Atenolol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000463	0.00122	CcSEcCtD
Atenolol—Insomnia—Triamcinolone—multiple sclerosis	0.000462	0.00122	CcSEcCtD
Atenolol—Insomnia—Methylprednisolone—multiple sclerosis	0.00046	0.00122	CcSEcCtD
Atenolol—Ill-defined disorder—Prednisone—multiple sclerosis	0.000458	0.00121	CcSEcCtD
Atenolol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000458	0.00121	CcSEcCtD
Atenolol—Feeling abnormal—Prednisolone—multiple sclerosis	0.000457	0.00121	CcSEcCtD
Atenolol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000457	0.00121	CcSEcCtD
Atenolol—Visual impairment—Methotrexate—multiple sclerosis	0.000457	0.00121	CcSEcCtD
Atenolol—Shock—Betamethasone—multiple sclerosis	0.000456	0.0012	CcSEcCtD
Atenolol—Shock—Dexamethasone—multiple sclerosis	0.000456	0.0012	CcSEcCtD
Atenolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000455	0.0012	CcSEcCtD
Atenolol—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000453	0.0012	CcSEcCtD
Atenolol—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000453	0.0012	CcSEcCtD
Atenolol—Tachycardia—Betamethasone—multiple sclerosis	0.000452	0.0012	CcSEcCtD
Atenolol—Tachycardia—Dexamethasone—multiple sclerosis	0.000452	0.0012	CcSEcCtD
Atenolol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000449	0.00119	CcSEcCtD
Atenolol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000448	0.00119	CcSEcCtD
Atenolol—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000448	0.00118	CcSEcCtD
Atenolol—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000448	0.00118	CcSEcCtD
Atenolol—Malaise—Prednisone—multiple sclerosis	0.000446	0.00118	CcSEcCtD
Atenolol—Vertigo—Prednisone—multiple sclerosis	0.000444	0.00117	CcSEcCtD
Atenolol—Syncope—Prednisone—multiple sclerosis	0.000443	0.00117	CcSEcCtD
Atenolol—Tinnitus—Methotrexate—multiple sclerosis	0.000442	0.00117	CcSEcCtD
Atenolol—Anorexia—Betamethasone—multiple sclerosis	0.000441	0.00117	CcSEcCtD
Atenolol—Anorexia—Dexamethasone—multiple sclerosis	0.000441	0.00117	CcSEcCtD
Atenolol—Fatigue—Triamcinolone—multiple sclerosis	0.00044	0.00116	CcSEcCtD
Atenolol—Fatigue—Methylprednisolone—multiple sclerosis	0.000439	0.00116	CcSEcCtD
Atenolol—Pain—Triamcinolone—multiple sclerosis	0.000436	0.00115	CcSEcCtD
Atenolol—Loss of consciousness—Prednisone—multiple sclerosis	0.000434	0.00115	CcSEcCtD
Atenolol—Hypotension—Dexamethasone—multiple sclerosis	0.000433	0.00114	CcSEcCtD
Atenolol—Hypotension—Betamethasone—multiple sclerosis	0.000433	0.00114	CcSEcCtD
Atenolol—Rash—Mitoxantrone—multiple sclerosis	0.000426	0.00113	CcSEcCtD
Atenolol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000426	0.00113	CcSEcCtD
Atenolol—Headache—Mitoxantrone—multiple sclerosis	0.000424	0.00112	CcSEcCtD
Atenolol—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00042	0.00111	CcSEcCtD
Atenolol—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00042	0.00111	CcSEcCtD
Atenolol—Anxiety—Prednisone—multiple sclerosis	0.000419	0.00111	CcSEcCtD
Atenolol—Alopecia—Methotrexate—multiple sclerosis	0.000419	0.00111	CcSEcCtD
Atenolol—Insomnia—Betamethasone—multiple sclerosis	0.000419	0.00111	CcSEcCtD
Atenolol—Insomnia—Dexamethasone—multiple sclerosis	0.000419	0.00111	CcSEcCtD
Atenolol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000416	0.0011	CcSEcCtD
Atenolol—Paraesthesia—Betamethasone—multiple sclerosis	0.000416	0.0011	CcSEcCtD
Atenolol—Discomfort—Prednisone—multiple sclerosis	0.000416	0.0011	CcSEcCtD
Atenolol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000408	0.00108	CcSEcCtD
Atenolol—Dyspepsia—Betamethasone—multiple sclerosis	0.000408	0.00108	CcSEcCtD
Atenolol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000403	0.00107	CcSEcCtD
Atenolol—Oedema—Prednisone—multiple sclerosis	0.000403	0.00107	CcSEcCtD
Atenolol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000402	0.00106	CcSEcCtD
Atenolol—Decreased appetite—Betamethasone—multiple sclerosis	0.000402	0.00106	CcSEcCtD
Atenolol—Nausea—Mitoxantrone—multiple sclerosis	0.000402	0.00106	CcSEcCtD
Atenolol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.0004	0.00106	CcSEcCtD
Atenolol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.0004	0.00106	CcSEcCtD
Atenolol—Fatigue—Betamethasone—multiple sclerosis	0.000399	0.00106	CcSEcCtD
Atenolol—Fatigue—Dexamethasone—multiple sclerosis	0.000399	0.00106	CcSEcCtD
Atenolol—Shock—Prednisone—multiple sclerosis	0.000397	0.00105	CcSEcCtD
Atenolol—Pain—Betamethasone—multiple sclerosis	0.000396	0.00105	CcSEcCtD
Atenolol—Pain—Dexamethasone—multiple sclerosis	0.000396	0.00105	CcSEcCtD
Atenolol—Tachycardia—Prednisone—multiple sclerosis	0.000394	0.00104	CcSEcCtD
Atenolol—Hyperhidrosis—Prednisone—multiple sclerosis	0.00039	0.00103	CcSEcCtD
Atenolol—Vision blurred—Methotrexate—multiple sclerosis	0.000389	0.00103	CcSEcCtD
Atenolol—Anorexia—Prednisone—multiple sclerosis	0.000384	0.00102	CcSEcCtD
Atenolol—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000383	0.00101	CcSEcCtD
Atenolol—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000382	0.00101	CcSEcCtD
Atenolol—Feeling abnormal—Betamethasone—multiple sclerosis	0.000382	0.00101	CcSEcCtD
Atenolol—Malaise—Methotrexate—multiple sclerosis	0.000372	0.000985	CcSEcCtD
Atenolol—Vertigo—Methotrexate—multiple sclerosis	0.000371	0.000981	CcSEcCtD
Atenolol—Dizziness—Prednisolone—multiple sclerosis	0.000367	0.000971	CcSEcCtD
Atenolol—Asthenia—Triamcinolone—multiple sclerosis	0.000366	0.000968	CcSEcCtD
Atenolol—Body temperature increased—Betamethasone—multiple sclerosis	0.000366	0.000968	CcSEcCtD
Atenolol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000366	0.000968	CcSEcCtD
Atenolol—Asthenia—Methylprednisolone—multiple sclerosis	0.000365	0.000966	CcSEcCtD
Atenolol—Insomnia—Prednisone—multiple sclerosis	0.000365	0.000965	CcSEcCtD
Atenolol—Paraesthesia—Prednisone—multiple sclerosis	0.000362	0.000958	CcSEcCtD
Atenolol—Pruritus—Triamcinolone—multiple sclerosis	0.000361	0.000955	CcSEcCtD
Atenolol—Cough—Methotrexate—multiple sclerosis	0.00036	0.000953	CcSEcCtD
Atenolol—Pruritus—Methylprednisolone—multiple sclerosis	0.00036	0.000953	CcSEcCtD
Atenolol—Dyspepsia—Prednisone—multiple sclerosis	0.000355	0.000939	CcSEcCtD
Atenolol—Chest pain—Methotrexate—multiple sclerosis	0.000352	0.00093	CcSEcCtD
Atenolol—Decreased appetite—Prednisone—multiple sclerosis	0.000351	0.000927	CcSEcCtD
Atenolol—Rash—Prednisolone—multiple sclerosis	0.00035	0.000925	CcSEcCtD
Atenolol—Dermatitis—Prednisolone—multiple sclerosis	0.00035	0.000925	CcSEcCtD
Atenolol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000348	0.000921	CcSEcCtD
Atenolol—Fatigue—Prednisone—multiple sclerosis	0.000348	0.00092	CcSEcCtD
Atenolol—Headache—Prednisolone—multiple sclerosis	0.000348	0.000919	CcSEcCtD
Atenolol—Discomfort—Methotrexate—multiple sclerosis	0.000347	0.000919	CcSEcCtD
Atenolol—Constipation—Prednisone—multiple sclerosis	0.000345	0.000912	CcSEcCtD
Atenolol—Confusional state—Methotrexate—multiple sclerosis	0.00034	0.000899	CcSEcCtD
Atenolol—Dizziness—Triamcinolone—multiple sclerosis	0.000337	0.000893	CcSEcCtD
Atenolol—Dizziness—Methylprednisolone—multiple sclerosis	0.000337	0.000891	CcSEcCtD
Atenolol—Feeling abnormal—Prednisone—multiple sclerosis	0.000332	0.000879	CcSEcCtD
Atenolol—Asthenia—Dexamethasone—multiple sclerosis	0.000332	0.000879	CcSEcCtD
Atenolol—Asthenia—Betamethasone—multiple sclerosis	0.000332	0.000879	CcSEcCtD
Atenolol—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00033	0.000873	CcSEcCtD
Atenolol—Nausea—Prednisolone—multiple sclerosis	0.00033	0.000872	CcSEcCtD
Atenolol—Pruritus—Betamethasone—multiple sclerosis	0.000328	0.000866	CcSEcCtD
Atenolol—Pruritus—Dexamethasone—multiple sclerosis	0.000328	0.000866	CcSEcCtD
Atenolol—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000326	0.000862	CcSEcCtD
Atenolol—Rash—Triamcinolone—multiple sclerosis	0.000322	0.000851	CcSEcCtD
Atenolol—Dermatitis—Triamcinolone—multiple sclerosis	0.000321	0.00085	CcSEcCtD
Atenolol—Anorexia—Methotrexate—multiple sclerosis	0.000321	0.00085	CcSEcCtD
Atenolol—Rash—Methylprednisolone—multiple sclerosis	0.000321	0.000849	CcSEcCtD
Atenolol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000321	0.000848	CcSEcCtD
Atenolol—Headache—Triamcinolone—multiple sclerosis	0.00032	0.000846	CcSEcCtD
Atenolol—Headache—Methylprednisolone—multiple sclerosis	0.000319	0.000844	CcSEcCtD
Atenolol—Body temperature increased—Prednisone—multiple sclerosis	0.000319	0.000843	CcSEcCtD
Atenolol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000317	0.000838	CcSEcCtD
Atenolol—Diarrhoea—Betamethasone—multiple sclerosis	0.000317	0.000838	CcSEcCtD
Atenolol—Hypotension—Methotrexate—multiple sclerosis	0.000315	0.000833	CcSEcCtD
Atenolol—Dizziness—Dexamethasone—multiple sclerosis	0.000306	0.00081	CcSEcCtD
Atenolol—Dizziness—Betamethasone—multiple sclerosis	0.000306	0.00081	CcSEcCtD
Atenolol—Insomnia—Methotrexate—multiple sclerosis	0.000305	0.000806	CcSEcCtD
Atenolol—Nausea—Triamcinolone—multiple sclerosis	0.000303	0.000802	CcSEcCtD
Atenolol—Paraesthesia—Methotrexate—multiple sclerosis	0.000303	0.0008	CcSEcCtD
Atenolol—Nausea—Methylprednisolone—multiple sclerosis	0.000302	0.0008	CcSEcCtD
Atenolol—Dyspnoea—Methotrexate—multiple sclerosis	0.0003	0.000795	CcSEcCtD
Atenolol—Somnolence—Methotrexate—multiple sclerosis	0.0003	0.000792	CcSEcCtD
Atenolol—Dyspepsia—Methotrexate—multiple sclerosis	0.000297	0.000785	CcSEcCtD
Atenolol—Decreased appetite—Methotrexate—multiple sclerosis	0.000293	0.000775	CcSEcCtD
Atenolol—Rash—Dexamethasone—multiple sclerosis	0.000292	0.000772	CcSEcCtD
Atenolol—Rash—Betamethasone—multiple sclerosis	0.000292	0.000772	CcSEcCtD
Atenolol—Dermatitis—Dexamethasone—multiple sclerosis	0.000292	0.000771	CcSEcCtD
Atenolol—Dermatitis—Betamethasone—multiple sclerosis	0.000292	0.000771	CcSEcCtD
Atenolol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000291	0.00077	CcSEcCtD
Atenolol—Fatigue—Methotrexate—multiple sclerosis	0.000291	0.000768	CcSEcCtD
Atenolol—Headache—Dexamethasone—multiple sclerosis	0.00029	0.000767	CcSEcCtD
Atenolol—Headache—Betamethasone—multiple sclerosis	0.00029	0.000767	CcSEcCtD
Atenolol—Asthenia—Prednisone—multiple sclerosis	0.000289	0.000765	CcSEcCtD
Atenolol—Pain—Methotrexate—multiple sclerosis	0.000288	0.000762	CcSEcCtD
Atenolol—Pruritus—Prednisone—multiple sclerosis	0.000285	0.000755	CcSEcCtD
Atenolol—Feeling abnormal—Methotrexate—multiple sclerosis	0.000278	0.000735	CcSEcCtD
Atenolol—Diarrhoea—Prednisone—multiple sclerosis	0.000276	0.00073	CcSEcCtD
Atenolol—Nausea—Dexamethasone—multiple sclerosis	0.000275	0.000727	CcSEcCtD
Atenolol—Nausea—Betamethasone—multiple sclerosis	0.000275	0.000727	CcSEcCtD
Atenolol—Dizziness—Prednisone—multiple sclerosis	0.000267	0.000705	CcSEcCtD
Atenolol—Body temperature increased—Methotrexate—multiple sclerosis	0.000266	0.000705	CcSEcCtD
Atenolol—Rash—Prednisone—multiple sclerosis	0.000254	0.000672	CcSEcCtD
Atenolol—Dermatitis—Prednisone—multiple sclerosis	0.000254	0.000672	CcSEcCtD
Atenolol—Headache—Prednisone—multiple sclerosis	0.000253	0.000668	CcSEcCtD
Atenolol—Asthenia—Methotrexate—multiple sclerosis	0.000242	0.00064	CcSEcCtD
Atenolol—Nausea—Prednisone—multiple sclerosis	0.000239	0.000634	CcSEcCtD
Atenolol—Pruritus—Methotrexate—multiple sclerosis	0.000238	0.000631	CcSEcCtD
Atenolol—Diarrhoea—Methotrexate—multiple sclerosis	0.000231	0.00061	CcSEcCtD
Atenolol—Ibuprofen—ALB—multiple sclerosis	0.000224	0.155	CrCbGaD
Atenolol—Dizziness—Methotrexate—multiple sclerosis	0.000223	0.000589	CcSEcCtD
Atenolol—Rash—Methotrexate—multiple sclerosis	0.000212	0.000562	CcSEcCtD
Atenolol—Dermatitis—Methotrexate—multiple sclerosis	0.000212	0.000562	CcSEcCtD
Atenolol—Headache—Methotrexate—multiple sclerosis	0.000211	0.000558	CcSEcCtD
Atenolol—Nausea—Methotrexate—multiple sclerosis	0.0002	0.000529	CcSEcCtD
Atenolol—ADRB1—Endothelin Pathways—MAPK1—multiple sclerosis	2.26e-06	0.00794	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	2.23e-06	0.00782	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Other—CCR5—multiple sclerosis	2.22e-06	0.00781	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	2.18e-06	0.00765	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	2.15e-06	0.00756	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—S1PR1—multiple sclerosis	2.11e-06	0.00739	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CD28—multiple sclerosis	2.09e-06	0.00734	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—S1PR1—multiple sclerosis	2.06e-06	0.00723	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	2.04e-06	0.00715	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	2.04e-06	0.00715	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	2e-06	0.00703	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	1.99e-06	0.007	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	1.99e-06	0.007	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	1.99e-06	0.00697	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CD40—multiple sclerosis	1.91e-06	0.0067	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	1.88e-06	0.00661	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	1.72e-06	0.00604	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—GPR65—multiple sclerosis	1.7e-06	0.00596	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—GPR65—multiple sclerosis	1.66e-06	0.00583	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	1.66e-06	0.00582	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	1.63e-06	0.00573	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	1.6e-06	0.0056	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	1.58e-06	0.00553	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCL13—multiple sclerosis	1.55e-06	0.00545	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCR1—multiple sclerosis	1.55e-06	0.00545	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.55e-06	0.00544	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	1.54e-06	0.00541	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	1.53e-06	0.00538	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCR1—multiple sclerosis	1.52e-06	0.00533	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL13—multiple sclerosis	1.52e-06	0.00533	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	1.5e-06	0.00526	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.49e-06	0.00524	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.46e-06	0.00514	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.46e-06	0.00514	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	1.45e-06	0.0051	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.42e-06	0.005	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	1.42e-06	0.00499	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	1.42e-06	0.00497	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	1.4e-06	0.00491	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.39e-06	0.00489	CbGpPWpGaD
Atenolol—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	1.39e-06	0.00487	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	1.38e-06	0.00486	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	1.37e-06	0.0048	CbGpPWpGaD
Atenolol—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	1.36e-06	0.00476	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	1.35e-06	0.00474	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	1.32e-06	0.00464	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	1.31e-06	0.00461	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.31e-06	0.00461	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.3e-06	0.00458	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.29e-06	0.00453	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	1.29e-06	0.00451	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	1.21e-06	0.00425	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	1.19e-06	0.00418	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	1.19e-06	0.00416	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.18e-06	0.00414	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	1.16e-06	0.00409	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	1.11e-06	0.00388	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	1.09e-06	0.00383	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.09e-06	0.00382	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	1.08e-06	0.0038	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	1.08e-06	0.00379	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	1.07e-06	0.00375	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	1.06e-06	0.00374	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	1.06e-06	0.00371	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	1.04e-06	0.00366	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	1.03e-06	0.00361	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	1.01e-06	0.00355	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	1.01e-06	0.00353	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	1e-06	0.00351	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	9.9e-07	0.00347	CbGpPWpGaD
Atenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	9.88e-07	0.00347	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	9.79e-07	0.00343	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.7e-07	0.0034	CbGpPWpGaD
Atenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	9.67e-07	0.00339	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	9.59e-07	0.00337	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	9.43e-07	0.00331	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	9.4e-07	0.0033	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	9.38e-07	0.00329	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	9.23e-07	0.00324	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	9.19e-07	0.00323	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	9.19e-07	0.00322	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	9.03e-07	0.00317	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	8.99e-07	0.00315	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	8.77e-07	0.00308	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	8.77e-07	0.00308	CbGpPWpGaD
Atenolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	8.77e-07	0.00308	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	8.71e-07	0.00306	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	8.61e-07	0.00302	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	8.58e-07	0.00301	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	8.58e-07	0.00301	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	8.52e-07	0.00299	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	8.47e-07	0.00297	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	8.42e-07	0.00296	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	8.31e-07	0.00292	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	8.28e-07	0.00291	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	8.24e-07	0.00289	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	8.13e-07	0.00285	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	7.97e-07	0.0028	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	7.97e-07	0.0028	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	7.79e-07	0.00274	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	7.79e-07	0.00274	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	7.68e-07	0.00269	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—IL2—multiple sclerosis	7.65e-07	0.00268	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.57e-07	0.00266	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.35e-07	0.00258	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	7.3e-07	0.00256	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	7.16e-07	0.00251	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	7.15e-07	0.00251	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	7e-07	0.00246	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.62e-07	0.00232	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.48e-07	0.00227	CbGpPWpGaD
Atenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.47e-07	0.00227	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	6.47e-07	0.00227	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	6.45e-07	0.00226	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	6.38e-07	0.00224	CbGpPWpGaD
Atenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	6.33e-07	0.00222	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	6.31e-07	0.00221	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	6.25e-07	0.00219	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	6.21e-07	0.00218	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	6.08e-07	0.00213	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	6.02e-07	0.00211	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—SRM—multiple sclerosis	5.99e-07	0.0021	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	5.97e-07	0.00209	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	5.89e-07	0.00207	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	5.81e-07	0.00204	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.81e-07	0.00204	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	5.69e-07	0.002	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	5.68e-07	0.00199	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	5.65e-07	0.00198	CbGpPWpGaD
Atenolol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	5.57e-07	0.00196	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	5.55e-07	0.00195	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	5.53e-07	0.00194	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	5.46e-07	0.00192	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	5.43e-07	0.00191	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	5.35e-07	0.00188	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	5.31e-07	0.00186	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	5.28e-07	0.00185	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	5.22e-07	0.00183	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	5.16e-07	0.00181	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	5.15e-07	0.00181	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.13e-07	0.0018	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	5.13e-07	0.0018	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	5.1e-07	0.00179	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	5.04e-07	0.00177	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	5.03e-07	0.00177	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	5.02e-07	0.00176	CbGpPWpGaD
Atenolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	4.93e-07	0.00173	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	4.93e-07	0.00173	CbGpPWpGaD
Atenolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	4.82e-07	0.00169	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	4.74e-07	0.00166	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	4.71e-07	0.00165	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	4.71e-07	0.00165	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	4.7e-07	0.00165	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	4.64e-07	0.00163	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	4.6e-07	0.00162	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	4.6e-07	0.00162	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	4.6e-07	0.00161	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	4.27e-07	0.0015	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	4.22e-07	0.00148	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	4.22e-07	0.00148	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	4.17e-07	0.00146	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	4.04e-07	0.00142	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	3.96e-07	0.00139	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—GPC5—multiple sclerosis	3.86e-07	0.00136	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	3.67e-07	0.00129	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	3.64e-07	0.00128	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	3.59e-07	0.00126	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.59e-07	0.00126	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	3.56e-07	0.00125	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.51e-07	0.00123	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	3.35e-07	0.00118	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	3.31e-07	0.00116	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	3.28e-07	0.00115	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	3.26e-07	0.00114	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	3.24e-07	0.00114	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	3.23e-07	0.00113	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—RRM1—multiple sclerosis	3.2e-07	0.00112	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	3.19e-07	0.00112	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	3.18e-07	0.00112	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	3.16e-07	0.00111	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	3.12e-07	0.00109	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	3.11e-07	0.00109	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	3.09e-07	0.00108	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	3.05e-07	0.00107	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	3.03e-07	0.00106	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	3.02e-07	0.00106	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	2.97e-07	0.00104	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.95e-07	0.00104	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.94e-07	0.00103	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.89e-07	0.00101	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	2.85e-07	0.000999	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	2.8e-07	0.000982	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	2.79e-07	0.000977	CbGpPWpGaD
Atenolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.75e-07	0.000965	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	2.74e-07	0.000961	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	2.59e-07	0.000907	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	2.53e-07	0.000888	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	2.53e-07	0.000888	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	2.52e-07	0.000884	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	2.47e-07	0.000869	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	2.47e-07	0.000865	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	2.3e-07	0.000806	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	2.25e-07	0.000789	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	2.2e-07	0.000773	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	2.17e-07	0.000761	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	2.16e-07	0.000757	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	2.12e-07	0.000745	CbGpPWpGaD
Atenolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	2.11e-07	0.000739	CbGpPWpGaD
Atenolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	2.06e-07	0.000723	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	2.01e-07	0.000705	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.97e-07	0.00069	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.95e-07	0.000686	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.93e-07	0.000676	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.91e-07	0.000671	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.91e-07	0.000671	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.88e-07	0.000661	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.87e-07	0.000656	CbGpPWpGaD
Atenolol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.85e-07	0.000649	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—BCHE—multiple sclerosis	1.84e-07	0.000645	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.78e-07	0.000624	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.74e-07	0.00061	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.61e-07	0.000564	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.57e-07	0.000552	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.53e-07	0.000536	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.49e-07	0.000524	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	1.49e-07	0.000524	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1.46e-07	0.000513	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	1.46e-07	0.000513	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	1.43e-07	0.000502	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	1.36e-07	0.000476	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	1.33e-07	0.000466	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	1.13e-07	0.000396	CbGpPWpGaD
Atenolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	1.12e-07	0.000394	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—APOE—multiple sclerosis	1.11e-07	0.000388	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	1.1e-07	0.000388	CbGpPWpGaD
Atenolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	1.1e-07	0.000386	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	1.07e-07	0.000375	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	1.05e-07	0.000367	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	9.5e-08	0.000333	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—POMC—multiple sclerosis	9.5e-08	0.000333	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	9.3e-08	0.000326	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	8.83e-08	0.00031	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	8.81e-08	0.000309	CbGpPWpGaD
Atenolol—ABCB1—Metabolism—ALB—multiple sclerosis	8.66e-08	0.000304	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	8.64e-08	0.000303	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	8.64e-08	0.000303	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	8.62e-08	0.000302	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	8.45e-08	0.000297	CbGpPWpGaD
Atenolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	6.64e-08	0.000233	CbGpPWpGaD
Atenolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	6.49e-08	0.000228	CbGpPWpGaD
